[ad_1]
VolitionRX (NYSE AMERICAN: VNRX) CEO Cameron Reynolds tells Proactive Investors the life sciences company chaired Capital Markets Day to bring together shareholders, company executives and badysts at the New York Stock Exchange.
The company plans to offer updates of results, ongoing projects and potential for new pathways to recovery, including trials in diagnosing lung cancer.
Source link
